Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Paul P. Cook (Creator)
Rosie S. Jones (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Language: English
Date: 2023
Subjects
Acute respiratory distress syndrome;Angiopoietin 2;COVID-19

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19http://hdl.handle.net/10342/11742The described resource references, cites, or otherwise points to the related resource.